SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 212 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $75,000 | +74.4% | 47,595 | +121.2% | 0.01% | +66.7% |
| Q2 2022 | $43,000 | -94.3% | 21,521 | -93.3% | 0.01% | -94.0% |
| Q1 2022 | $748,000 | +364.6% | 321,129 | +825.4% | 0.10% | +400.0% |
| Q4 2021 | $161,000 | -40.4% | 34,701 | -1.9% | 0.02% | -28.6% |
| Q3 2021 | $270,000 | +26.8% | 35,363 | +37.0% | 0.03% | -20.0% |
| Q1 2021 | $213,000 | +69.0% | 25,808 | +40.1% | 0.04% | +66.7% |
| Q4 2020 | $126,000 | -77.5% | 18,418 | -76.4% | 0.02% | -25.0% |
| Q2 2018 | $561,000 | -53.8% | 77,895 | -66.9% | 0.03% | -56.2% |
| Q1 2018 | $1,213,000 | +1361.4% | 235,495 | +1283.7% | 0.06% | +1180.0% |
| Q4 2016 | $83,000 | -20.2% | 17,019 | +42.6% | 0.01% | 0.0% |
| Q4 2015 | $104,000 | -88.9% | 11,933 | -89.4% | 0.01% | -89.1% |
| Q3 2015 | $940,000 | +214.4% | 112,067 | +332.9% | 0.05% | +283.3% |
| Q1 2015 | $299,000 | – | 25,889 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |